Clarivate Transformative Intelligence

Clarivate Plc is a global leader in transformative intelligence, dedicated to boosting research and innovation across various domains. The company provides advanced tools designed to facilitate enhanced research excellence and outcomes. Recently, Clarivate appointed Matti Shem Tov as the new CEO, effective August 9, 2024, indicating a strong leadership transition.

Among its recent innovations, Clarivate launched the OFF-X™ platform, which is tailored for preclinical and clinical safety intelligence, ensuring robust safety assessments in drug development. This platform exemplifies the integration of artificial intelligence into Clarivate's offerings, improving user experiences and insights.

Additionally, the acquisition of Rowan TELS Corp. has reinforced Clarivate's commitment to providing comprehensive support for patent practitioners, thereby streamlining processes in intellectual property management.

Clarivate also highlights its dedication to sustainability and collaboration, working closely with customers and partners to achieve meaningful results. Their recent announcement of the 2023 Highly Cited Researchers list underscores the importance of recognizing influential contributors in research. Overall, Clarivate remains focused on enhancing innovation through collaboration and state-of-the-art solutions.